Assay Development
Our experts start with the end in mind to tailor assays for the
right targets in the right patients on the right platforms.
Preliminary
Research
- Determine the best commercially-available and novel/proprietary primary antibodies for targets of interest
- Select appropriate controls and test tissues from the world’s largest commercial FFPE biorepository.
- Optimized dual DNA/RNA extraction services
- Genomic biomarker analyses: RNA-Seq, whole exome sequencing and targeted sequencing, whole genome sequencing, long read sequencing, single cell and more
- Immunophentyping and functional analyses via flow cytometry and cell-based services
Tissue Biomarker
Assay Optimization
- Experienced & proven proprietary assay development approaches for IHC, ISH and multiplex IF
- In depth analysis of all possible pretreatment conditions
- Titration of primary antibody concentration & selection of optimal assays and detection systems
- Includes testing of Intended to Treat Population
- App development for digital pathology
- Orthogonal testing via RNAScope, PCR, ELISA, Nanostring, etc.
- Genomic biomarker analyses: RNA-Seq, whole exome sequencing and targeted sequencing, whole genome sequencing, long read sequencing, single cell and more
- Immunophentyping and functional analyses via flow cytometry and cell-based services
To propel your projects with The Power of Discovery.™
Contact Us Today
Let us know about your project!
